Ke Ding

66PUBLICATIONS
93CO-AUTHORS
Tissue engineeringReaction engineering (excl. nuclear reactions)Wastewater treatment processesPredictive and prognostic markersCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Oct 23, 2026
Development of DCL1191 as a Potent, Selective and Orally Bioavailable Inhibitor for Autophagy-Associated Transcription Factor EB (TFEB).

|Oct 23, 2026
Single-Atom Modification Enables Reversal of Degradation Selectivity between NSD2 and GSPT1.

|Aug 19, 2026
A New Recruitable E3 Ligase UHRF1 Supporting Targeted Protein Degradation: A Minimal Azide as a Recruitment Ligand.

|Jul 07, 2026
A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer.

|Jun 08, 2026
Structure-Based Design and Optimization of Novel, Potent and Selective Covalent FGFR2/3 Inhibitors with a Tricyclic Core.

|May 29, 2026
Discovery of a Potent, Selective and In Vivo Active Aurora A PROTAC Degrader from a Promiscuous Kinase Inhibitor.

Pageof 11

Frequent Collaborators

20 joint publications

Zhen Wang

15 joint publications

Xiaoyun Lu

14 joint publications

Yang Zhou

10 joint publications

Zhengqiu Li